Evidence map›Paper›PMID 37261072›Full record

ArticleFrontiers in cell and developmental biology2023

Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling.

Kinga Wilkus-Adamczyk, Klaudia Brodaczewska, Aleksandra Majewska, Claudine Kieda

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kinga Wilkus-AdamczykLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine- National Research Institute, Warsaw, Poland.
Klaudia BrodaczewskaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine- National Research Institute, Warsaw, Poland.
Aleksandra MajewskaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine- National Research Institute, Warsaw, Poland.
Claudine KiedaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine- National Research Institute, Warsaw, Poland.
Medical University of Warsaw · PLCentre National de la Recherche Scientifique · FRNarodowy Instytut Leków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerECM-receptor interaction (extracellular matrix-receptor interaction)endothelial cells (ECs)endothelial to mesenchymal transition (EndMT)heterogeneitymiR-200b-3p

Identifiers

PMID37261072
PMCPMC10229062
OpenAlexW4376890862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.